These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30686784)

  • 1. [Research progress of super enhancer in cancer].
    Wu ZQ; Mi ZY
    Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super enhancer lncRNAs: a novel hallmark in cancer.
    Song P; Han R; Yang F
    Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
    Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
    Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super-enhancers complexes zoom in transcription in cancer.
    Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
    J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-enhancers and novel therapeutic targets in colorectal cancer.
    Liu Q; Guo L; Lou Z; Xiang X; Shao J
    Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
    Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
    Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
    Dębek S; Juszczyński P
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super-enhancers in the control of cell identity and disease.
    Hnisz D; Abraham BJ; Lee TI; Lau A; Saint-André V; Sigova AA; Hoke HA; Young RA
    Cell; 2013 Nov; 155(4):934-47. PubMed ID: 24119843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.
    Liu S; Dai W; Jin B; Jiang F; Huang H; Hou W; Lan J; Jin Y; Peng W; Pan J
    Mol Cancer; 2024 Jun; 23(1):122. PubMed ID: 38844984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.
    Hnisz D; Schuijers J; Lin CY; Weintraub AS; Abraham BJ; Lee TI; Bradner JE; Young RA
    Mol Cell; 2015 Apr; 58(2):362-70. PubMed ID: 25801169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are super-enhancers?
    Pott S; Lieb JD
    Nat Genet; 2015 Jan; 47(1):8-12. PubMed ID: 25547603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advance in the research on super-enhancer.
    Sun CB; Zhang X
    Yi Chuan; 2016 Dec; 38(12):1056-1068. PubMed ID: 28034838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
    Chen X; Ma Q; Shang Z; Niu Y
    NPJ Precis Oncol; 2020 Nov; 4(1):31. PubMed ID: 33299103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
    Bacabac M; Xu W
    Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super-enhancers: Implications in gastric cancer.
    Huang Y; Huo Y; Huang L; Zhang L; Zheng Y; Zhang N; Yang M
    Mutat Res Rev Mutat Res; 2024; 793():108489. PubMed ID: 38355091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2.
    Cui S; Wu Q; Liu M; Su M; Liu S; Shao L; Han X; He H
    Cell Death Dis; 2021 Mar; 12(3):264. PubMed ID: 33712565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies.
    Jia Y; Chng WJ; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):77. PubMed ID: 31311566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted regulation of enhancers in cancer.
    Xiao Q; Xiao Y; Li LY; Chen MK; Wu M
    Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194839. PubMed ID: 35750313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.